Belgium· BE-AMP-SAM002554-00

Nivaquine 100 mg

A chloroquine product containing chloroquine sulfate, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 7 of our 19 countries.

ATC P01BA01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNivaquine 100 mgATCP01BA01REGISTER NO.BE-AMP-SAM002554-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Chloroquine is registered in 7 of 19 countries.

Countries holding a registration under ATC P01BA01 (chloroquine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose

Chloroquine · ATC P01BA01

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of chloroquine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Chloroquine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • FR France$1.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Chloroquine Sulfate
Manufacturer
Sanofi Belgium
Country
Belgium (BE)
ATC code
P01BA01
ATC class
Chloroquine
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0121913
  • be_apb
    0061119

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

557 interactions on record for chloroquine.

Graded by severity as the source publishes them — 221 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chloroquine · interactions on record

557 records

  • 221 severe
  • 306 moderate
  • 14 minor
  • 16 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chloroquine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chloroquine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Cyprus · Chloroquine Phosphate Remedica
  • Spain · Resochín
  • United Kingdom (Northern Ireland) · Avloclor, Chloroquine Phosphate Bristol Laboratories
  • Greece · Unikinon
  • Hungary · Delagil
  • Netherlands · A-Cq 100
  • Portugal · Cloroquina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd16dcca-0c77-4379-b761-9d515d129dd7
GET /v1/drugs/fd16dcca-0c77-4379-b761-9d515d129dd7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Nivaquine 100 mg",
  "name_fr": "Nivaquine 100 mg",
  "name_nl": "Nivaquine 100 mg",
  "amp_code": "SAM002554-00",
  "strengths": [
    "136.0000",
    "100.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Chloroquine Sulfate",
    "Chloroquine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Chloroquine",
  "authorisation_numbers": [
    "BE002554"
  ]
}

See everything about chloroquine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.